Perrigo (PRGO) Liabilities and Shareholders Equity (2013 - 2026)

Perrigo's (PRGO) quarterly Liabilities and Shareholders Equity came in at $8.0 billion in Q1 2026, down 18.2% year-on-year from $9.8 billion in Q1 2025, and down 6.47% on a QoQ basis from $8.5 billion in Q4 2025.

Perrigo (PRGO) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends

Perrigo (PRGO) has 14 years of Liabilities and Shareholders Equity data on file, last reported at $8.0 billion in Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 18.2% year-over-year to $8.0 billion in Q1 2026; TTM through Mar 2026 was $36.7 billion, a 10.51% decrease from a year earlier, with the FY2025 full-year figure at $8.5 billion, down 11.53% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $8.0 billion, down from $8.5 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for PRGO reached as high as $11.2 billion in Q3 2024 and fell as low as $8.0 billion in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $10.3 billion across 5 years, with a median of $10.6 billion in 2024.
  • Across the five-year window, Liabilities and Shareholders Equity gained 5.67% in 2022 and slipped 18.2% in 2026, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $11.0 billion in 2022, then decreased by 1.89% to $10.8 billion in 2023, then dropped by 10.74% to $9.6 billion in 2024, then fell by 11.53% to $8.5 billion in 2025, then decreased by 6.47% to $8.0 billion in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $8.0 billion in Q1 2026, $8.5 billion in Q4 2025, and $10.1 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 43.40 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 40.04 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 15.15 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 98.91 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 6.71 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 69.30 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 36.83 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4.91 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.22 Bn
10 Perrigo 1.40 Bn 1.05 Bn 325.50 Mn 7.98 Bn

Historic Data

Download Data
DateValue
Mar 28, 2026 7.98 Bn
Dec 31, 2025 8.54 Bn
Sep 27, 2025 10.08 Bn
Jun 28, 2025 10.09 Bn
Mar 29, 2025 9.76 Bn
Dec 31, 2024 9.65 Bn
Sep 28, 2024 11.20 Bn
Jun 29, 2024 10.40 Bn
Mar 30, 2024 10.64 Bn
Dec 31, 2023 10.81 Bn
Sep 30, 2023 10.76 Bn
Jul 1, 2023 10.96 Bn
Apr 1, 2023 10.95 Bn
Dec 31, 2022 11.02 Bn
Oct 1, 2022 10.68 Bn
Jul 2, 2022 10.92 Bn
Apr 2, 2022 10.39 Bn
Dec 31, 2021 10.43 Bn
Oct 2, 2021 10.92 Bn
Jul 3, 2021 11.23 Bn